Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Sep. 30, 2015 |
Jun. 30, 2015 |
|
| Chemo Centryx, Inc. [Member] | ||
| Available-for-sale Securities, Amortized Cost Basis | $ 29,500 | |
| Available-for-sale Securities, Amortized Cost Basis | $ 29,500 | 33,600 |
| Inventory Valuation Reserves | 24,000 | 24,000 |
| Available-for-sale Securities | 38,400 | 56,400 |
| Available-for-sale Securities, Gross Unrealized Gain (Loss) | (3,900) | |
| Inventory, Net | $ 58,967 | $ 49,577 |
| X | ||||||||||
- Definition Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investments in debt and equity securities classified as available-for-sale securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of valuation reserve for inventory. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|